Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

about

IgG-single-chain TRAIL fusion proteins for tumour therapy.

P2860

Q54998541-D3ECD368-7267-4CB4-906B-1556EFE76737

P2860

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

Item

http://www.wikidata.org/entity/Q55012569

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

@en

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

@nl

type

Item

label

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

@en

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

@nl

prefLabel

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

@en

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

@nl

P1476

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

@en

P2093

Klaus Pfizenmaier

http://www.w3.org/2001/XMLSchema#string

Meike Hutt

http://www.w3.org/2001/XMLSchema#string

Oliver Seifert

http://www.w3.org/2001/XMLSchema#string

Roland E Kontermann

http://www.w3.org/2001/XMLSchema#string

Sina Fellermeier-Kopf

http://www.w3.org/2001/XMLSchema#string

P2860

Humanization of an anti-p185HER2 antibody for human cancer therapy

The emerging role of EpCAM in cancer and stem cell signaling

Superior antitumoral activity of dimerized targeted single-chain TRAIL fusion proteins under retention of tumor selectivity

Tetravalent antibody-scTRAIL fusion proteins with improved properties.

An Fcγ receptor-dependent mechanism drives antibody-mediated target-receptor signaling in cancer cells.

Safety and antitumor activity of recombinant soluble Apo2 ligand.

EGFR-targeted TRAIL and a Smac mimetic synergize to overcome apoptosis resistance in KRAS mutant colorectal cancer cells.

Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.

Potent antitumoral activity of TRAIL through generation of tumor-targeted single-chain fusion proteins.

The tetravalent anti-DR5 antibody without cross-linking direct induces apoptosis of cancer cells.

P304

11322-11335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24379

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lisa C Schmitt

P577

2018-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29541416

http://www.w3.org/2001/XMLSchema#string

P932

5834252

http://www.w3.org/2001/XMLSchema#string

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

about

P2860

P2860

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932